.jpg "Chunze Li, PhD photo")
Executive Director, Head of Oncology Clinical Pharmacology
Genentech
Chunze is currently an Executive Director/Sr Principal Scientist and Head of Oncology Clinical Pharmacology at Genentech. She oversees strategic clinical pharmacology support for the oncology portfolios, including Immune-cell bispecifics, cell therapy, cancer vaccine, small molecules, antibody-drug conjugates, immuno-Oncology, SC development for biologics. She is passionate about strategic implementation of quantitative clinical pharmacology to accelerate the oncology drug development. Prior to Genentech, Chunze worked as Associate Director at Pfizer and as Research Fellow at Merck to provided Clin Pharm and DMPK support in drug discovery and development of small molecules and therapeutic proteins across multiple diseases. Chunze obtained her PhD degree in Pharmaceutical Chemistry at UCSF with Dr. Leslie Z. Benet. She has published over 60 peer-reviewed papers and book chapters in the field of clinical pharmacology, drug metabolism and pharmacokinetics. She is currently the Vice-Chair of IQ Clinical Pharmacology leadership group (CPLG) and has served as the 2020 Chair of ASCPT Pharmacometrics & Pharmacokinetics (PMK) community.
Disclosure information not submitted.
Tuesday, January 11, 2022
10:00 AM – 11:00 AM ET
.png)